{
  "DOI": "10.1186/s40246-022-00386-z",
  "ISSN": [
    "1479-7364"
  ],
  "URL": "http://dx.doi.org/10.1186/s40246-022-00386-z",
  "abstract": "\u003cjats:title\u003eAbstract\u003c/jats:title\u003e\u003cjats:sec\u003e\u003cjats:title\u003eBackground\u003c/jats:title\u003e\u003cjats:p\u003eGastric cancer (GC) shows high metastasis and low survival. RNA modification writers play critical roles in tumor development. This study examined the clinical significance of RNA modification writers in GC prognosis based on four types of adenosine modifications (m\u003cjats:sup\u003e1\u003c/jats:sup\u003eA, m\u003cjats:sup\u003e6\u003c/jats:sup\u003eA, APA and A-to-I).\u003c/jats:p\u003e\u003c/jats:sec\u003e\u003cjats:sec\u003e\u003cjats:title\u003eResults\u003c/jats:title\u003e\u003cjats:p\u003eWriters demonstrated high mutation and expression in GC patients. Different expressions of 26 RNA modification writers were differentially associated with GC prognosis. High-WM score group appeared worse overall survival, higher immune infiltration and activation of EMT pathways than low-WM score group. WM score was correlated with both miRNAs-targeted signaling pathways and patients’ sensitivity to chemotherapeutic drugs and efficacy of immunotherapy.\u003c/jats:p\u003e\u003c/jats:sec\u003e\u003cjats:sec\u003e\u003cjats:title\u003eConclusions\u003c/jats:title\u003e\u003cjats:p\u003eThis study further revealed the close association between adenosine-related RNA modifications and progression of GC. A cross talk between EMT and RNA modification was identified to be one of the mechanisms underlying GC development. Our WM scoring system could serve as a clinical indicator for predicting GC prognosis. Importantly, the WM score could guide personalized treatments such as chemotherapy and immunotherapy for GC patients.\u003c/jats:p\u003e\u003c/jats:sec\u003e",
  "alternative-id": [
    "386"
  ],
  "article-number": "14",
  "assertion": [
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Received",
      "name": "received",
      "order": 1,
      "value": "26 August 2021"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Accepted",
      "name": "accepted",
      "order": 2,
      "value": "28 March 2022"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "First Online",
      "name": "first_online",
      "order": 3,
      "value": "22 April 2022"
    },
    {
      "group": {
        "label": "Declarations",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 1
    },
    {
      "group": {
        "label": "Ethics approval and consent to participate",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 2,
      "value": "The experimental procedures were approved by the Institutional Ethics Committee of The Second Affiliated Hospital of Guangzhou Medical University."
    },
    {
      "group": {
        "label": "Consent for publication",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 3,
      "value": "Not applicable."
    },
    {
      "group": {
        "label": "Competing interests",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 4,
      "value": "The authors declare that they have no competing interests."
    }
  ],
  "author": [
    {
      "affiliation": [],
      "family": "Zhang",
      "given": "Shi",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "family": "Kuang",
      "given": "Guanghao",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Huang",
      "given": "Yao",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Huang",
      "given": "Xinxin",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Wang",
      "given": "Weiyu",
      "sequence": "additional"
    },
    {
      "ORCID": "http://orcid.org/0000-0002-5172-3749",
      "affiliation": [],
      "authenticated-orcid": false,
      "family": "Wang",
      "given": "Guoqiang",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "Human Genomics"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": [
      "link.springer.com"
    ]
  },
  "created": {
    "date-parts": [
      [
        2022,
        4,
        22
      ]
    ],
    "date-time": "2022-04-22T04:08:53Z",
    "timestamp": 1650600533000
  },
  "deposited": {
    "date-parts": [
      [
        2023,
        2,
        3
      ]
    ],
    "date-time": "2023-02-03T00:13:48Z",
    "timestamp": 1675383228000
  },
  "funder": [
    {
      "award": [
        "2016C18"
      ],
      "name": "Guangzhou Medical University Dr's Start-up Project"
    }
  ],
  "indexed": {
    "date-parts": [
      [
        2023,
        9,
        15
      ]
    ],
    "date-time": "2023-09-15T02:24:55Z",
    "timestamp": 1694744695876
  },
  "is-referenced-by-count": 5,
  "issn-type": [
    {
      "type": "electronic",
      "value": "1479-7364"
    }
  ],
  "issue": "1",
  "issued": {
    "date-parts": [
      [
        2022,
        4,
        22
      ]
    ]
  },
  "journal-issue": {
    "issue": "1",
    "published-print": {
      "date-parts": [
        [
          2022,
          12
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "https://creativecommons.org/licenses/by/4.0",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2022,
            4,
            22
          ]
        ],
        "date-time": "2022-04-22T00:00:00Z",
        "timestamp": 1650585600000
      }
    },
    {
      "URL": "https://creativecommons.org/licenses/by/4.0",
      "content-version": "vor",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2022,
            4,
            22
          ]
        ],
        "date-time": "2022-04-22T00:00:00Z",
        "timestamp": 1650585600000
      }
    }
  ],
  "link": [
    {
      "URL": "https://link.springer.com/content/pdf/10.1186/s40246-022-00386-z.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://link.springer.com/article/10.1186/s40246-022-00386-z/fulltext.html",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://link.springer.com/content/pdf/10.1186/s40246-022-00386-z.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "prefix": "10.1186",
  "published": {
    "date-parts": [
      [
        2022,
        4,
        22
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2022,
        4,
        22
      ]
    ]
  },
  "published-print": {
    "date-parts": [
      [
        2022,
        12
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "DOI": "10.3322/caac.21660",
      "author": "H Sung",
      "doi-asserted-by": "crossref",
      "first-page": "209",
      "issue": "3",
      "journal-title": "CA Cancer J Clin",
      "key": "386_CR1",
      "unstructured": "Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality Worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–49.",
      "volume": "71",
      "year": "2021"
    },
    {
      "author": "SM Wang",
      "first-page": "1517",
      "issue": "12",
      "journal-title": "Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi",
      "key": "386_CR2",
      "unstructured": "Wang SM, Zheng RS, Zhang SW, Zeng HM, Chen R, Sun KX, et al. Epidemiological characteristics of gastric cancer in China, 2015. Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi. 2019;40(12):1517–21.",
      "volume": "40",
      "year": "2019"
    },
    {
      "DOI": "10.1038/nrgastro.2017.53",
      "author": "N Padmanabhan",
      "doi-asserted-by": "publisher",
      "first-page": "467",
      "issue": "8",
      "journal-title": "Nat Rev Gastroenterol Hepatol",
      "key": "386_CR3",
      "unstructured": "Padmanabhan N, Ushijima T, Tan P. How to stomach an epigenetic insult: the gastric cancer epigenome. Nat Rev Gastroenterol Hepatol. 2017;14(8):467–78.",
      "volume": "14",
      "year": "2017"
    },
    {
      "DOI": "10.1016/S0140-6736(20)31288-5",
      "author": "EC Smyth",
      "doi-asserted-by": "publisher",
      "first-page": "635",
      "issue": "10251",
      "journal-title": "Lancet",
      "key": "386_CR4",
      "unstructured": "Smyth EC, Nilsson M, Grabsch HI, van Grieken NC, Lordick F. Gastric cancer. Lancet. 2020;396(10251):635–48.",
      "volume": "396",
      "year": "2020"
    },
    {
      "DOI": "10.1186/s12943-020-01159-9",
      "author": "X Yang",
      "doi-asserted-by": "publisher",
      "first-page": "64",
      "issue": "1",
      "journal-title": "Mol Cancer",
      "key": "386_CR5",
      "unstructured": "Yang X, Liu M, Li M, Zhang S, Hiju H, Sun J, et al. Epigenetic modulations of noncoding RNA: a novel dimension of cancer biology. Mol Cancer. 2020;19(1):64.",
      "volume": "19",
      "year": "2020"
    },
    {
      "DOI": "10.1016/j.omtn.2021.03.023",
      "author": "Q Meng",
      "doi-asserted-by": "publisher",
      "first-page": "695",
      "journal-title": "Mol Ther Nucleic Acids",
      "key": "386_CR6",
      "unstructured": "Meng Q, Lu YX, Ruan DY, Yu K, Chen YX, Xiao M, et al. DNA methylation regulator-mediated modification patterns and tumor microenvironment characterization in gastric cancer. Mol Ther Nucleic Acids. 2021;24:695–710.",
      "volume": "24",
      "year": "2021"
    },
    {
      "DOI": "10.2217/fon-2020-0630",
      "author": "JJ Jing",
      "doi-asserted-by": "publisher",
      "first-page": "2605",
      "issue": "20",
      "journal-title": "Future Oncol",
      "key": "386_CR7",
      "unstructured": "Jing JJ, Zhao X, Li H, Sun LP, Yuan Y. Expression profiles and prognostic roles of m6A writers, erasers and readers in gastric cancer. Future Oncol. 2021;17(20):2605–20.",
      "volume": "17",
      "year": "2021"
    },
    {
      "DOI": "10.3389/fonc.2019.01038",
      "author": "Y Su",
      "doi-asserted-by": "publisher",
      "first-page": "1038",
      "journal-title": "Front Oncol",
      "key": "386_CR8",
      "unstructured": "Su Y, Huang J, Hu J. m(6)A RNA methylation regulators contribute to malignant progression and have clinical prognostic impact in gastric cancer. Front Oncol. 2019;9:1038.",
      "volume": "9",
      "year": "2019"
    },
    {
      "DOI": "10.1186/s12943-019-1099-7",
      "author": "BB Hu",
      "doi-asserted-by": "publisher",
      "first-page": "178",
      "issue": "1",
      "journal-title": "Mol Cancer",
      "key": "386_CR9",
      "unstructured": "Hu BB, Wang XY, Gu XY, Zou C, Gao ZJ, Zhang H, et al. N(6)-methyladenosine (m(6)A) RNA modification in gastrointestinal tract cancers: roles, mechanisms, and applications. Mol Cancer. 2019;18(1):178.",
      "volume": "18",
      "year": "2019"
    },
    {
      "DOI": "10.1016/j.cell.2017.05.045",
      "author": "IA Roundtree",
      "doi-asserted-by": "publisher",
      "first-page": "1187",
      "issue": "7",
      "journal-title": "Cell",
      "key": "386_CR10",
      "unstructured": "Roundtree IA, Evans ME, Pan T, He C. Dynamic RNA modifications in gene expression regulation. Cell. 2017;169(7):1187–200.",
      "volume": "169",
      "year": "2017"
    },
    {
      "DOI": "10.1016/j.omtn.2019.11.022",
      "author": "W Zhao",
      "doi-asserted-by": "publisher",
      "first-page": "405",
      "journal-title": "Mol Ther Nucleic Acids",
      "key": "386_CR11",
      "unstructured": "Zhao W, Qi X, Liu L, Ma S, Liu J, Wu J. Epigenetic regulation of m(6)A modifications in human cancer. Mol Ther Nucleic Acids. 2020;19:405–12.",
      "volume": "19",
      "year": "2020"
    },
    {
      "DOI": "10.1002/cam4.2360",
      "author": "C Zhang",
      "doi-asserted-by": "publisher",
      "first-page": "4766",
      "issue": "10",
      "journal-title": "Cancer Med",
      "key": "386_CR12",
      "unstructured": "Zhang C, Zhang M, Ge S, Huang W, Lin X, Gao J, et al. Reduced m6A modification predicts malignant phenotypes and augmented Wnt/PI3K-Akt signaling in gastric cancer. Cancer Med. 2019;8(10):4766–81.",
      "volume": "8",
      "year": "2019"
    },
    {
      "DOI": "10.1186/s12943-020-01170-0",
      "author": "B Zhang",
      "doi-asserted-by": "publisher",
      "first-page": "53",
      "issue": "1",
      "journal-title": "Mol Cancer",
      "key": "386_CR13",
      "unstructured": "Zhang B, Wu Q, Li B, Wang D, Wang L, Zhou YL. m(6)A regulator-mediated methylation modification patterns and tumor microenvironment infiltration characterization in gastric cancer. Mol Cancer. 2020;19(1):53.",
      "volume": "19",
      "year": "2020"
    },
    {
      "DOI": "10.1080/15476286.2017.1282025",
      "author": "X Wang",
      "doi-asserted-by": "publisher",
      "first-page": "300",
      "issue": "3",
      "journal-title": "RNA Biol",
      "key": "386_CR14",
      "unstructured": "Wang X, Huang J, Zou T, Yin P. Human m(6)A writers: two subunits, 2 roles. RNA Biol. 2017;14(3):300–4.",
      "volume": "14",
      "year": "2017"
    },
    {
      "DOI": "10.1016/j.biopha.2019.108613",
      "author": "T Sun",
      "doi-asserted-by": "publisher",
      "first-page": "108613",
      "journal-title": "Biomed Pharmacother",
      "key": "386_CR15",
      "unstructured": "Sun T, Wu R, Ming L. The role of m6A RNA methylation in cancer. Biomed Pharmacother. 2019;112:108613.",
      "volume": "112",
      "year": "2019"
    },
    {
      "DOI": "10.1186/s12943-019-1033-z",
      "author": "XY Chen",
      "doi-asserted-by": "publisher",
      "first-page": "103",
      "issue": "1",
      "journal-title": "Mol Cancer",
      "key": "386_CR16",
      "unstructured": "Chen XY, Zhang J, Zhu JS. The role of m(6)A RNA methylation in human cancer. Mol Cancer. 2019;18(1):103.",
      "volume": "18",
      "year": "2019"
    },
    {
      "DOI": "10.1016/j.bbcan.2021.188609",
      "author": "H Zhou",
      "doi-asserted-by": "publisher",
      "first-page": "188609",
      "issue": "2",
      "journal-title": "Biochim Biophys Acta Rev Cancer",
      "key": "386_CR17",
      "unstructured": "Zhou H, Yin K, Zhang Y, Tian J, Wang S. The RNA m6A writer METTL14 in cancers: roles, structures, and applications. Biochim Biophys Acta Rev Cancer. 2021;1876(2):188609.",
      "volume": "1876",
      "year": "2021"
    },
    {
      "DOI": "10.1186/s13045-020-00951-w",
      "author": "C Zeng",
      "doi-asserted-by": "publisher",
      "first-page": "117",
      "issue": "1",
      "journal-title": "J Hematol Oncol",
      "key": "386_CR18",
      "unstructured": "Zeng C, Huang W, Li Y, Weng H. Roles of METTL3 in cancer: mechanisms and therapeutic targeting. J Hematol Oncol. 2020;13(1):117.",
      "volume": "13",
      "year": "2020"
    },
    {
      "DOI": "10.1038/s41568-020-0253-2",
      "author": "I Barbieri",
      "doi-asserted-by": "publisher",
      "first-page": "303",
      "issue": "6",
      "journal-title": "Nat Rev Cancer",
      "key": "386_CR19",
      "unstructured": "Barbieri I, Kouzarides T. Role of RNA modifications in cancer. Nat Rev Cancer. 2020;20(6):303–22.",
      "volume": "20",
      "year": "2020"
    },
    {
      "DOI": "10.1016/j.tranon.2019.06.007",
      "author": "Y Zhao",
      "doi-asserted-by": "publisher",
      "first-page": "1323",
      "issue": "10",
      "journal-title": "Transl Oncol",
      "key": "386_CR20",
      "unstructured": "Zhao Y, Zhao Q, Kaboli PJ, Shen J, Li M, Wu X, et al. m1A regulated genes modulate PI3K/AKT/mTOR and ErbB pathways in gastrointestinal cancer. Transl Oncol. 2019;12(10):1323–33.",
      "volume": "12",
      "year": "2019"
    },
    {
      "DOI": "10.1038/nrm.2016.116",
      "author": "B Tian",
      "doi-asserted-by": "publisher",
      "first-page": "18",
      "issue": "1",
      "journal-title": "Nat Rev Mol Cell Biol",
      "key": "386_CR21",
      "unstructured": "Tian B, Manley JL. Alternative polyadenylation of mRNA precursors. Nat Rev Mol Cell Biol. 2017;18(1):18–30.",
      "volume": "18",
      "year": "2017"
    },
    {
      "DOI": "10.1016/j.cell.2009.06.016",
      "author": "C Mayr",
      "doi-asserted-by": "publisher",
      "first-page": "673",
      "issue": "4",
      "journal-title": "Cell",
      "key": "386_CR22",
      "unstructured": "Mayr C, Bartel DP. Widespread shortening of 3′UTRs by alternative cleavage and polyadenylation activates oncogenes in cancer cells. Cell. 2009;138(4):673–84.",
      "volume": "138",
      "year": "2009"
    },
    {
      "DOI": "10.1038/ncomms6274",
      "author": "Z Xia",
      "doi-asserted-by": "publisher",
      "first-page": "5274",
      "journal-title": "Nat Commun",
      "key": "386_CR23",
      "unstructured": "Xia Z, Donehower LA, Cooper TA, Neilson JR, Wheeler DA, Wagner EJ, et al. Dynamic analyses of alternative polyadenylation from RNA-seq reveal a 3′-UTR landscape across seven tumour types. Nat Commun. 2014;5:5274.",
      "volume": "5",
      "year": "2014"
    },
    {
      "DOI": "10.3389/fgene.2021.707644",
      "author": "X Shi",
      "doi-asserted-by": "publisher",
      "first-page": "707644",
      "journal-title": "Front Genet",
      "key": "386_CR24",
      "unstructured": "Shi X, Ding K, Zhao Q, Li P, Kang Y, Tan S, et al. Suppression of CPSF6 enhances apoptosis through alternative polyadenylation-mediated shortening of the VHL 3′UTR in gastric cancer cells. Front Genet. 2021;12:707644.",
      "volume": "12",
      "year": "2021"
    },
    {
      "DOI": "10.1093/nar/gkx1176",
      "author": "Y Pinto",
      "doi-asserted-by": "publisher",
      "first-page": "71",
      "issue": "1",
      "journal-title": "Nucleic Acids Res",
      "key": "386_CR25",
      "unstructured": "Pinto Y, Buchumenski I, Levanon EY, Eisenberg E. Human cancer tissues exhibit reduced A-to-I editing of miRNAs coupled with elevated editing of their targets. Nucleic Acids Res. 2018;46(1):71–82.",
      "volume": "46",
      "year": "2018"
    },
    {
      "DOI": "10.1053/j.gastro.2016.06.043",
      "author": "TH Chan",
      "doi-asserted-by": "publisher",
      "first-page": "637",
      "issue": "4",
      "journal-title": "Gastroenterology",
      "key": "386_CR26",
      "unstructured": "Chan TH, Qamra A, Tan KT, Guo J, Yang H, Qi L, et al. ADAR-mediated RNA editing predicts progression and prognosis of gastric cancer. Gastroenterology. 2016;151(4):637-50.e10.",
      "volume": "151",
      "year": "2016"
    },
    {
      "DOI": "10.1186/s12943-021-01322-w",
      "author": "H Chen",
      "doi-asserted-by": "publisher",
      "first-page": "29",
      "issue": "1",
      "journal-title": "Mol Cancer",
      "key": "386_CR27",
      "unstructured": "Chen H, Yao J, Bao R, Dong Y, Zhang T, Du Y, et al. Cross-talk of four types of RNA modification writers defines tumor microenvironment and pharmacogenomic landscape in colorectal cancer. Mol Cancer. 2021;20(1):29.",
      "volume": "20",
      "year": "2021"
    },
    {
      "DOI": "10.18632/aging.103407",
      "author": "T Chen",
      "doi-asserted-by": "publisher",
      "first-page": "13172",
      "issue": "13",
      "journal-title": "Aging",
      "key": "386_CR28",
      "unstructured": "Chen T, Zhao Z, Chen B, Wang Y, Yang F, Wang C, et al. An individualized transcriptional signature to predict the epithelial–mesenchymal transition based on relative expression ordering. Aging. 2020;12(13):13172–86.",
      "volume": "12",
      "year": "2020"
    },
    {
      "DOI": "10.1158/1078-0432.CCR-15-0876",
      "author": "MP Mak",
      "doi-asserted-by": "publisher",
      "first-page": "609",
      "issue": "3",
      "journal-title": "Clin Cancer Res",
      "key": "386_CR29",
      "unstructured": "Mak MP, Tong P, Diao L, Cardnell RJ, Gibbons DL, William WN, et al. A patient-derived, pan-cancer EMT signature identifies global molecular alterations and immune target enrichment following epithelial-to-mesenchymal transition. Clin Cancer Res. 2016;22(3):609–20.",
      "volume": "22",
      "year": "2016"
    },
    {
      "DOI": "10.1038/s41698-021-00200-4",
      "author": "G Wang",
      "doi-asserted-by": "publisher",
      "first-page": "56",
      "issue": "1",
      "journal-title": "NPJ Precis Oncol",
      "key": "386_CR30",
      "unstructured": "Wang G, Xu D, Zhang Z, Li X, Shi J, Sun J, et al. The pan-cancer landscape of crosstalk between epithelial–mesenchymal transition and immune evasion relevant to prognosis and immunotherapy response. NPJ Precis Oncol. 2021;5(1):56.",
      "volume": "5",
      "year": "2021"
    },
    {
      "DOI": "10.1016/j.semcdb.2017.08.056",
      "author": "RE Turner",
      "doi-asserted-by": "publisher",
      "first-page": "61",
      "journal-title": "Semin Cell Dev Biol",
      "key": "386_CR31",
      "unstructured": "Turner RE, Pattison AD, Beilharz TH. Alternative polyadenylation in the regulation and dysregulation of gene expression. Semin Cell Dev Biol. 2018;75:61–9.",
      "volume": "75",
      "year": "2018"
    },
    {
      "DOI": "10.1101/gr.231506.117",
      "author": "Y Fu",
      "doi-asserted-by": "publisher",
      "first-page": "1656",
      "issue": "11",
      "journal-title": "Genome Res",
      "key": "386_CR32",
      "unstructured": "Fu Y, Chen L, Chen C, Ge Y, Kang M, Song Z, et al. Crosstalk between alternative polyadenylation and miRNAs in the regulation of protein translational efficiency. Genome Res. 2018;28(11):1656–63.",
      "volume": "28",
      "year": "2018"
    },
    {
      "DOI": "10.1136/gutjnl-2019-319639",
      "author": "Q Wang",
      "doi-asserted-by": "publisher",
      "first-page": "1193",
      "issue": "7",
      "journal-title": "Gut",
      "key": "386_CR33",
      "unstructured": "Wang Q, Chen C, Ding Q, Zhao Y, Wang Z, Chen J, et al. METTL3-mediated m(6)A modification of HDGF mRNA promotes gastric cancer progression and has prognostic significance. Gut. 2020;69(7):1193–205.",
      "volume": "69",
      "year": "2020"
    },
    {
      "DOI": "10.1038/s41419-020-2487-z",
      "author": "L Mei",
      "doi-asserted-by": "publisher",
      "first-page": "270",
      "issue": "4",
      "journal-title": "Cell Death Dis",
      "key": "386_CR34",
      "unstructured": "Mei L, Shen C, Miao R, Wang JZ, Cao MD, Zhang YS, et al. RNA methyltransferase NSUN2 promotes gastric cancer cell proliferation by repressing p57(Kip2) by an m(5)C-dependent manner. Cell Death Dis. 2020;11(4):270.",
      "volume": "11",
      "year": "2020"
    },
    {
      "DOI": "10.1016/j.omtn.2021.07.007",
      "author": "H Han",
      "doi-asserted-by": "publisher",
      "first-page": "333",
      "journal-title": "Mol Ther Nucleic Acids",
      "key": "386_CR35",
      "unstructured": "Han H, Yang C, Zhang S, Cheng M, Guo S, Zhu Y, et al. METTL3-mediated m(6)A mRNA modification promotes esophageal cancer initiation and progression via Notch signaling pathway. Mol Ther Nucleic Acids. 2021;26:333–46.",
      "volume": "26",
      "year": "2021"
    },
    {
      "DOI": "10.15252/embj.2020104514",
      "author": "L Wang",
      "doi-asserted-by": "publisher",
      "first-page": "e104514",
      "issue": "20",
      "journal-title": "EMBO J",
      "key": "386_CR36",
      "unstructured": "Wang L, Hui H, Agrawal K, Kang Y, Li N, Tang R, et al. m(6) A RNA methyltransferases METTL3/14 regulate immune responses to anti-PD-1 therapy. EMBO J. 2020;39(20):e104514.",
      "volume": "39",
      "year": "2020"
    },
    {
      "DOI": "10.1007/s00535-013-0748-7",
      "author": "HJ Jo",
      "doi-asserted-by": "publisher",
      "first-page": "1271",
      "issue": "11",
      "journal-title": "J Gastroenterol",
      "key": "386_CR37",
      "unstructured": "Jo HJ, Shim HE, Han ME, Kim HJ, Kim KS, Baek S, et al. WTAP regulates migration and invasion of cholangiocarcinoma cells. J Gastroenterol. 2013;48(11):1271–82.",
      "volume": "48",
      "year": "2013"
    },
    {
      "DOI": "10.1186/s12943-019-1106-z",
      "author": "T Lan",
      "doi-asserted-by": "publisher",
      "first-page": "186",
      "issue": "1",
      "journal-title": "Mol Cancer",
      "key": "386_CR38",
      "unstructured": "Lan T, Li H, Zhang D, Xu L, Liu H, Hao X, et al. KIAA1429 contributes to liver cancer progression through N6-methyladenosine-dependent post-transcriptional modification of GATA3. Mol Cancer. 2019;18(1):186.",
      "volume": "18",
      "year": "2019"
    },
    {
      "DOI": "10.1038/s41590-020-0650-4",
      "author": "Z Shulman",
      "doi-asserted-by": "publisher",
      "first-page": "501",
      "issue": "5",
      "journal-title": "Nat Immunol",
      "key": "386_CR39",
      "unstructured": "Shulman Z, Stern-Ginossar N. The RNA modification N(6)-methyladenosine as a novel regulator of the immune system. Nat Immunol. 2020;21(5):501–12.",
      "volume": "21",
      "year": "2020"
    },
    {
      "DOI": "10.1038/s41576-018-0006-1",
      "author": "E Eisenberg",
      "doi-asserted-by": "publisher",
      "first-page": "473",
      "issue": "8",
      "journal-title": "Nat Rev Genet",
      "key": "386_CR40",
      "unstructured": "Eisenberg E, Levanon EY. A-to-I RNA editing—immune protector and transcriptome diversifier. Nat Rev Genet. 2018;19(8):473–90.",
      "volume": "19",
      "year": "2018"
    },
    {
      "DOI": "10.1038/s41591-018-0014-x",
      "author": "M Binnewies",
      "doi-asserted-by": "publisher",
      "first-page": "541",
      "issue": "5",
      "journal-title": "Nat Med",
      "key": "386_CR41",
      "unstructured": "Binnewies M, Roberts EW, Kersten K, Chan V, Fearon DF, Merad M, et al. Understanding the tumor immune microenvironment (TIME) for effective therapy. Nat Med. 2018;24(5):541–50.",
      "volume": "24",
      "year": "2018"
    },
    {
      "DOI": "10.1158/0008-5472.CAN-15-0255",
      "author": "MW Teng",
      "doi-asserted-by": "publisher",
      "first-page": "2139",
      "issue": "11",
      "journal-title": "Can Res",
      "key": "386_CR42",
      "unstructured": "Teng MW, Ngiow SF, Ribas A, Smyth MJ. Classifying cancers based on T-cell infiltration and PD-L1. Can Res. 2015;75(11):2139–45.",
      "volume": "75",
      "year": "2015"
    },
    {
      "DOI": "10.1016/j.devcel.2008.05.009",
      "author": "J Yang",
      "doi-asserted-by": "publisher",
      "first-page": "818",
      "issue": "6",
      "journal-title": "Dev Cell",
      "key": "386_CR43",
      "unstructured": "Yang J, Weinberg RA. Epithelial–mesenchymal transition: at the crossroads of development and tumor metastasis. Dev Cell. 2008;14(6):818–29.",
      "volume": "14",
      "year": "2008"
    },
    {
      "DOI": "10.1111/j.1349-7006.2009.01419.x",
      "author": "M Iwatsuki",
      "doi-asserted-by": "publisher",
      "first-page": "293",
      "issue": "2",
      "journal-title": "Cancer Sci",
      "key": "386_CR44",
      "unstructured": "Iwatsuki M, Mimori K, Yokobori T, Ishi H, Beppu T, Nakamori S, et al. Epithelial–mesenchymal transition in cancer development and its clinical significance. Cancer Sci. 2010;101(2):293–9.",
      "volume": "101",
      "year": "2010"
    },
    {
      "DOI": "10.1038/s41580-018-0080-4",
      "author": "A Dongre",
      "doi-asserted-by": "publisher",
      "first-page": "69",
      "issue": "2",
      "journal-title": "Nat Rev Mol Cell Biol",
      "key": "386_CR45",
      "unstructured": "Dongre A, Weinberg RA. New insights into the mechanisms of epithelial–mesenchymal transition and implications for cancer. Nat Rev Mol Cell Biol. 2019;20(2):69–84.",
      "volume": "20",
      "year": "2019"
    },
    {
      "DOI": "10.1002/dvdy.24485",
      "author": "DL Gibbons",
      "doi-asserted-by": "publisher",
      "first-page": "555",
      "issue": "3",
      "journal-title": "Dev Dyn",
      "key": "386_CR46",
      "unstructured": "Gibbons DL, Creighton CJ. Pan-cancer survey of epithelial–mesenchymal transition markers across the Cancer Genome Atlas. Dev Dyn. 2018;247(3):555–64.",
      "volume": "247",
      "year": "2018"
    },
    {
      "DOI": "10.1038/s41598-017-04234-2",
      "author": "M Rokavec",
      "doi-asserted-by": "publisher",
      "first-page": "4687",
      "issue": "1",
      "journal-title": "Sci Rep",
      "key": "386_CR47",
      "unstructured": "Rokavec M, Kaller M, Horst D, Hermeking H. Pan-cancer EMT-signature identifies RBM47 down-regulation during colorectal cancer progression. Sci Rep. 2017;7(1):4687.",
      "volume": "7",
      "year": "2017"
    },
    {
      "DOI": "10.3389/fgene.2021.661306",
      "author": "W Dai",
      "doi-asserted-by": "publisher",
      "first-page": "661306",
      "journal-title": "Front Genet",
      "key": "386_CR48",
      "unstructured": "Dai W, Xiao Y, Tang W, Li J, Hong L, Zhang J, et al. Identification of an EMT-related gene signature for predicting overall survival in gastric cancer. Front Genet. 2021;12:661306.",
      "volume": "12",
      "year": "2021"
    },
    {
      "DOI": "10.1038/s41419-019-1397-4",
      "author": "P Peixoto",
      "doi-asserted-by": "publisher",
      "first-page": "205",
      "issue": "3",
      "journal-title": "Cell Death Dis",
      "key": "386_CR49",
      "unstructured": "Peixoto P, Etcheverry A, Aubry M, Missey A, Lachat C, Perrard J, et al. EMT is associated with an epigenetic signature of ECM remodeling genes. Cell Death Dis. 2019;10(3):205.",
      "volume": "10",
      "year": "2019"
    },
    {
      "DOI": "10.1002/hep.28885",
      "author": "JZ Ma",
      "doi-asserted-by": "publisher",
      "first-page": "529",
      "issue": "2",
      "journal-title": "Hepatology",
      "key": "386_CR50",
      "unstructured": "Ma JZ, Yang F, Zhou CC, Liu F, Yuan JH, Wang F, et al. METTL14 suppresses the metastatic potential of hepatocellular carcinoma by modulating N(6) -methyladenosine-dependent primary MicroRNA processing. Hepatology. 2017;65(2):529–43.",
      "volume": "65",
      "year": "2017"
    },
    {
      "DOI": "10.1016/j.molcel.2016.03.021",
      "author": "S Lin",
      "doi-asserted-by": "publisher",
      "first-page": "335",
      "issue": "3",
      "journal-title": "Mol Cell",
      "key": "386_CR51",
      "unstructured": "Lin S, Choe J, Du P, Triboulet R, Gregory RI. The m(6)A methyltransferase METTL3 promotes translation in human cancer cells. Mol Cell. 2016;62(3):335–45.",
      "volume": "62",
      "year": "2016"
    },
    {
      "DOI": "10.1038/s41467-019-09865-9",
      "author": "X Lin",
      "doi-asserted-by": "publisher",
      "first-page": "2065",
      "issue": "1",
      "journal-title": "Nat Commun",
      "key": "386_CR52",
      "unstructured": "Lin X, Chai G, Wu Y, Li J, Chen F, Liu J, et al. RNA m(6)A methylation regulates the epithelial mesenchymal transition of cancer cells and translation of Snail. Nat Commun. 2019;10(1):2065.",
      "volume": "10",
      "year": "2019"
    },
    {
      "DOI": "10.1002/hep.29683",
      "author": "M Chen",
      "doi-asserted-by": "publisher",
      "first-page": "2254",
      "issue": "6",
      "journal-title": "Hepatology",
      "key": "386_CR53",
      "unstructured": "Chen M, Wei L, Law CT, Tsang FH, Shen J, Cheng CL, et al. RNA N6-methyladenosine methyltransferase-like 3 promotes liver cancer progression through YTHDF2-dependent posttranscriptional silencing of SOCS2. Hepatology. 2018;67(6):2254–70.",
      "volume": "67",
      "year": "2018"
    },
    {
      "DOI": "10.1093/bioinformatics/btq170",
      "author": "MD Wilkerson",
      "doi-asserted-by": "publisher",
      "first-page": "1572",
      "issue": "12",
      "journal-title": "Bioinformatics",
      "key": "386_CR54",
      "unstructured": "Wilkerson MD, Hayes DN. ConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking. Bioinformatics. 2010;26(12):1572–3.",
      "volume": "26",
      "year": "2010"
    },
    {
      "DOI": "10.1186/1471-2105-14-7",
      "author": "S Hänzelmann",
      "doi-asserted-by": "publisher",
      "first-page": "7",
      "journal-title": "BMC Bioinform",
      "key": "386_CR55",
      "unstructured": "Hänzelmann S, Castelo R, Guinney J. GSVA: gene set variation analysis for microarray and RNA-seq data. BMC Bioinform. 2013;14:7.",
      "volume": "14",
      "year": "2013"
    },
    {
      "DOI": "10.1093/bioinformatics/btw512",
      "author": "SG Gaffney",
      "doi-asserted-by": "crossref",
      "first-page": "3688",
      "issue": "23",
      "journal-title": "Bioinformatics",
      "key": "386_CR56",
      "unstructured": "Gaffney SG, Townsend JP. PathScore: a web tool for identifying altered pathways in cancer data. Bioinformatics. 2016;32(23):3688–90.",
      "volume": "32",
      "year": "2016"
    },
    {
      "DOI": "10.1089/omi.2011.0118",
      "author": "G Yu",
      "doi-asserted-by": "publisher",
      "first-page": "284",
      "issue": "5",
      "journal-title": "OMICS",
      "key": "386_CR57",
      "unstructured": "Yu G, Wang LG, Han Y, He QY. clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS. 2012;16(5):284–7.",
      "volume": "16",
      "year": "2012"
    },
    {
      "DOI": "10.1007/978-1-4939-7493-1_12",
      "author": "B Chen",
      "doi-asserted-by": "publisher",
      "first-page": "243",
      "journal-title": "Methods Mol Biol",
      "key": "386_CR58",
      "unstructured": "Chen B, Khodadoust MS, Liu CL, Newman AM, Alizadeh AA. Profiling tumor infiltrating immune cells with CIBERSORT. Methods Mol Biol. 2018;1711:243–59.",
      "volume": "1711",
      "year": "2018"
    },
    {
      "DOI": "10.1093/nar/gkv007",
      "author": "ME Ritchie",
      "doi-asserted-by": "publisher",
      "first-page": "e47",
      "issue": "7",
      "journal-title": "Nucleic Acids Res",
      "key": "386_CR59",
      "unstructured": "Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43(7):e47.",
      "volume": "43",
      "year": "2015"
    },
    {
      "DOI": "10.1002/sim.5958",
      "author": "P Blanche",
      "doi-asserted-by": "publisher",
      "first-page": "5381",
      "issue": "30",
      "journal-title": "Stat Med",
      "key": "386_CR60",
      "unstructured": "Blanche P, Dartigues JF, Jacqmin-Gadda H. Estimating and comparing time-dependent areas under receiver operating characteristic curves for censored event times with competing risks. Stat Med. 2013;32(30):5381–97.",
      "volume": "32",
      "year": "2013"
    },
    {
      "DOI": "10.1093/jnci/djy168",
      "author": "VL Cannataro",
      "doi-asserted-by": "publisher",
      "first-page": "1171",
      "issue": "11",
      "journal-title": "J Natl Cancer Inst",
      "key": "386_CR61",
      "unstructured": "Cannataro VL, Gaffney SG, Townsend JP. Effect sizes of somatic mutations in cancer. J Natl Cancer Inst. 2018;110(11):1171–7.",
      "volume": "110",
      "year": "2018"
    },
    {
      "author": "W Yang",
      "first-page": "D955",
      "issue": "Database issue",
      "journal-title": "Nucleic acids Res",
      "key": "386_CR62",
      "unstructured": "Yang W, Soares J, Greninger P, Edelman EJ, Lightfoot H, Forbes S, et al. Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells. Nucleic acids Res. 2013;41(Database issue):D955–61.",
      "volume": "41",
      "year": "2013"
    },
    {
      "DOI": "10.1371/journal.pone.0107468",
      "author": "P Geeleher",
      "doi-asserted-by": "publisher",
      "first-page": "e107468",
      "issue": "9",
      "journal-title": "PLoS ONE",
      "key": "386_CR63",
      "unstructured": "Geeleher P, Cox N, Huang RS. pRRophetic: an R package for prediction of clinical chemotherapeutic response from tumor gene expression levels. PLoS ONE. 2014;9(9):e107468.",
      "volume": "9",
      "year": "2014"
    }
  ],
  "reference-count": 63,
  "references-count": 63,
  "resource": {
    "primary": {
      "URL": "https://humgenomics.biomedcentral.com/articles/10.1186/s40246-022-00386-z"
    }
  },
  "score": 0,
  "short-container-title": [
    "Hum Genomics"
  ],
  "source": "Crossref",
  "title": [
    "Cross talk between RNA modification writers and tumor development as a basis for guiding personalized therapy of gastric cancer"
  ],
  "type": "journal-article",
  "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy",
  "volume": "16"
}